Inpharma Weekly

, Volume 1325, Issue 1, pp 21–21 | Cite as

Parecoxib vs ketorolac: risk of gastroduodenal mucosal injury

Incidence study


Placebo Placebo Group Duodenal Ulcer Placebo Recipient Multiple Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2002

Personalised recommendations